Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled, Non-inferiority Clinical Trial to Evaluate the Efficacy and Safety of the AbsnowTM II Absorbable Atrial Septal Defect Occluder System for Atrial Septal Defect Closure Therapy

NCT07529028 is registered in ClinicalTrials.gov with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor.

NCT NCT07529028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07529028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled, Non-inferiority Clinical Trial to Evaluate the Efficacy and Safety of the AbsnowTM II Absorbable Atrial Septal Defect Occluder System for Atrial Septal Defect Closure Therapy
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
December 31, 2031
Enrollment
236 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial septal defect